{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:37:31Z","timestamp":1790703451334,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.medmal.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T13:00:47Z","timestamp":1366117247000},"page":"195-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Papillomavirus vaccine coverage and its determinants in South-Eastern France"],"prefix":"10.1016","volume":"43","author":[{"given":"C.","family":"Lions","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pulcini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.medmal.2013.03.003_bib0005","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejca.2009.07.019","article-title":"HPV infection in Europe","volume":"45","author":"De Vuyst","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.medmal.2013.03.003_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gyobfe.2008.11.012","article-title":"Assessing the incidence of papillomavirus infections in France","volume":"37","author":"Detournay","year":"2009","journal-title":"Gynecol Obstet Fertil"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2013.03.003_bib0015","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections","volume":"32","author":"Baseman","year":"2005","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.medmal.2013.03.003_bib0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1503\/cmaj.070948","article-title":"Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials","volume":"177","author":"Rambout","year":"2007","journal-title":"CMAJ"},{"issue":"9706","key":"10.1016\/j.medmal.2013.03.003_bib0025","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(09)61567-1","article-title":"Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years","volume":"374","author":"Romanowski","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2013.03.003_bib0155","first-page":"161","article-title":"Le Calendrier des vaccinations et les recommandations vaccinales 2012\u00a0selon l\u2019avis du Haut Conseil de la sant\u00e9 publique","volume":"14-15","author":"Insitut de Veille Sanitaire","year":"2012","journal-title":"Bull Epidemiol Hebd"},{"issue":"19","key":"10.1016\/j.medmal.2013.03.003_bib0035","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.vaccine.2011.02.064","article-title":"HPV vaccination in France: uptake, costs and issues for the National Health Insurance","volume":"29","author":"Fagot","year":"2011","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.medmal.2013.03.003_bib0040","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.vaccine.2012.03.063","article-title":"Factors associated with HPV vaccine uptake in teenage girls: a systematic review","volume":"30","author":"Kessels","year":"2012","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.medmal.2013.03.003_bib0045","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.47.19730-en","article-title":"The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey","volume":"15","author":"Dorleans","year":"2010","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.medmal.2013.03.003_bib0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jadohealth.2010.04.006","article-title":"Coverage and compliance of Human Papilloma Virus vaccines in Paris: demonstration of low compliance with non-school-based approaches","volume":"47","author":"Rouzier","year":"2010","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.medmal.2013.03.003_bib0055","series-title":"Observatoire r\u00e9gional de la sant\u00e9 d\u2019\u00cele-de-France, Institut national de pr\u00e9vention et d\u2019\u00e9ducation pour la sant\u00e9","article-title":"Les connaissances, attitudes, croyances et comportements face au VIH\/Sida en France. \u00c9volutions 1992\u20131994\u20131998\u20132001\u20132004. \u00c9tude ANRS-EN15-KABP 2004, Paris","author":"Beltzer","year":"2005"},{"issue":"Suppl. 3","key":"10.1016\/j.medmal.2013.03.003_bib0060","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2009.06.003","article-title":"Self-reported sexual debut and behavior in young adults aged 18-24 years in seven European countries: implications for HPV vaccination programs","volume":"115","author":"Crochard","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"Suppl. 10","key":"10.1016\/j.medmal.2013.03.003_bib0065","doi-asserted-by":"crossref","first-page":"K53","DOI":"10.1016\/j.vaccine.2008.06.002","article-title":"An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results","volume":"26","author":"Schiller","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.medmal.2013.03.003_bib0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1542\/peds.2011-0950","article-title":"Human papillomavirus vaccination series initiation and completion, 2008\u20132009","volume":"128","author":"Dorell","year":"2011","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.medmal.2013.03.003_bib0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00128360-200407000-00005","article-title":"Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents","volume":"8","author":"Davis","year":"2004","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"10.1016\/j.medmal.2013.03.003_bib0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1552-6909.2008.00304.x","article-title":"Human papillomavirus, current vaccines, and cervical cancer prevention","volume":"38","author":"Teitelman","year":"2009","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2013.03.003_bib0085","doi-asserted-by":"crossref","first-page":"s23","DOI":"10.1097\/01.gco.0000216317.10690.8f","article-title":"Understanding and overcoming barriers to human papillomavirus vaccine acceptance","volume":"18","author":"Zimet","year":"2006","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.medmal.2013.03.003_bib0090","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.AOG.0000228509.11502.d2","article-title":"Will widespread human papillomavirus prophylactic vaccination change sexual practices of adolescent and young adult women in America?","volume":"108","author":"Monk","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.medmal.2013.03.003_bib0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jpag.2006.09.010","volume":"19","author":"Nicoletti","year":"2006","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"9","key":"10.1016\/j.medmal.2013.03.003_bib0100","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.vaccine.2009.12.042","article-title":"Determinants for HPV vaccine uptake in the Netherlands: A multilevel study","volume":"28","author":"Rondy","year":"2010","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.medmal.2013.03.003_bib0105","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1016\/j.vaccine.2012.09.028","article-title":"Human papillomavirus vaccination coverage among Greek higher education female students and predictors of vaccine uptake","volume":"30","author":"Donadiki","year":"2012","journal-title":"Vaccine"},{"issue":"51","key":"10.1016\/j.medmal.2013.03.003_bib0110","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1016\/j.vaccine.2008.08.067","article-title":"Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006\u2013January 2008","volume":"26","author":"Koulova","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2013.03.003_bib0115","first-page":"997","article-title":"National State, and local area vaccination coverage among adolescents aged 13-17 years\u00a0\u2013\u00a0United States, 2008","volume":"58","year":"2009","journal-title":"MMWR"},{"issue":"1","key":"10.1016\/j.medmal.2013.03.003_bib0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.AOG.0000266984.23445.9c","article-title":"Sociodemographic factors associated with high-risk human papillomavirus infection","volume":"110","author":"Kahn","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.medmal.2013.03.003_bib0125","first-page":"417","article-title":"Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study","volume":"20","author":"Clegg","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"Suppl. 2","key":"10.1016\/j.medmal.2013.03.003_bib0130","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.ygyno.2008.01.003","article-title":"The disparity of cervical cancer in diverse populations","volume":"109","author":"Downs","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.medmal.2013.03.003_bib0135","series-title":"Excess cervical cancer mortality: a marker for low access to health care in poor communities. Rockville: md: national cancer institute","author":"Freeman","year":"2005"},{"issue":"3","key":"10.1016\/j.medmal.2013.03.003_bib0140","first-page":"242s","article-title":"Cervical cancer: disparities in screening, treatment, and survival","volume":"12","author":"Garner","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.medmal.2013.03.003_bib0145","first-page":"1721","article-title":"Does socioeconomic disparity in cancer incidence vary across racial\/ethnic groups?","volume":"21","author":"Yin","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.medmal.2013.03.003_bib0150","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1748-0361.2010.00354.x","article-title":"Uptake of free HPV vaccination among young women: a comparison of rural versus urban rates","volume":"27","author":"Crosby","year":"2011","journal-title":"J Rural Health"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X13000723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X13000723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:12:03Z","timestamp":1759972323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X13000723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0399077X13000723"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2013.03.003","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Papillomavirus vaccine coverage and its determinants in South-Eastern France","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2013.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}